Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-27 @ 11:49 AM
Study NCT ID:
NCT01096160
Status:
COMPLETED
Last Update Posted:
2019-08-12
First Post:
2010-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8266 in Hypertensive Men (MK-8266-002)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2010-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-26
First Submit QC Date:
None
Study First Post Date:
2010-03-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-02-21
Results First Submit QC Date:
None
Results First Post Date:
2019-08-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-06-24
Last Update Post Date:
2019-08-12
Last Update Post Date Type:
ACTUAL